PowerShares DWA Utilities Momentum Portfolio PUI 深 沪
已收盘 08-01 16:00:00 美东时间
44.3379
-0.066
-0.15%
华盛通- 最 高44.58
- 今 开44.239
- 成交量 6733股
- 最 低 44.1255
- 昨 收 44.4043
- 总市值 7448.77万
- 52周最高 44.58
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 35.6983
- 委 比 -35.28%
- 总股本 168.00万
- 历史最高 44.58
- 量 比 3.61
- 振 幅 1.02%
- 历史最低 12.8892
- 每 手 1
- 风险率 1.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Barclays downgrades Puig Brands, S.A. (PUIG) to a Hold
In a report released today, Patrick Folan from Barclays downgraded Puig Brands,...
07-15 17:27
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
ReShape Lifesciences® announced the issuance of U.S. Patent 12,350,179, covering an intragastric balloon system with a swallowable capsule, self-sealing fill valve, and degradable release valve. The patent, set to be issued on July 8, 2025, provides protection until at least January 2031 and strengthens the company's intellectual property portfolio, which now includes over 160 issued and pending patents. The company also noted its agreement to se...
07-01 12:31
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
ReShape Lifesciences Inc. announced a strategic workforce reduction,预计每年节省超过75万美元，占工资支出的23.4%。The company retained its sales and marketing team to continue promoting the Lap-Band® system and expanding internationally in Canada. ReShape also updated progress on its merger with Vyome Therapeutics and asset sale to Biorad Medisys, with a shareholder meeting scheduled for July 24, 2025. The company emphasized these moves as transformative opportuniti...
06-26 12:31
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Recon Supply has been named the exclusive U.S. distributor of ReShape Lifesciences' products, including the STIMEL-03 neuromuscular rehabilitation device and Lap-Band® 2.0 FLEX. This partnership aims to expand access to these innovative medical technologies for over 18 million U.S. veterans and active-duty service members through the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. The collaboration highlights both...
06-12 12:25
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
ReShape Lifesciences (Nasdaq: RSLS) announced the pricing of its public offering of 1,054,604 shares at $2.50 each, expected to raise approximately $2.6 million. The offering, led by Maxim Group LLC, is set to close on June 9, 2025. ReShape, a leader in weight loss and metabolic health solutions, offers FDA-approved products like Lap-Band systems and innovative technologies such as the ReShape Diabetes Neuromodulation system and Obalon gastric ba...
06-09 13:00
What's Going On With WEC Energy Shares Monday?
WEC Energy to acquire 90% ownership of Delilah I Solar Energy Center for $459 million. Commercial operation expected by June. Exciting addition to clean energy portfolio.
2024-04-30 01:13
